Literature DB >> 10951334

Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms.

T Mikami1, H Mitomi, A Hara, N Yanagisawa, T Yoshida, O Tsuruta, I Okayasu.   

Abstract

BACKGROUND: To clarify the cell adhesion status in ulcerative colitis (UC)-associated colon neoplasm, expression of cell adhesion molecules were investigated and compared with that of sporadic colon neoplasm.
METHODS: A total of 14 low grade dysplasias, 16 high grade dysplasias, and 8 adenocarcinomas associated with UC and 17 sporadic adenomas with mild to moderate dysplasia, 22 adenomas with severe dysplasia, and 15 invasive adenocarcinomas were immunohistochemically examined using monoclonal antibodies against CD44, E-cadherin, alpha- and beta-catenin, and deleted colon carcinoma (DCC).
RESULTS: CD44, especially its standard form, and DCC expression was stronger in the sporadic colon neoplasms than in the UC-associated lesions. Although E-cadherin did not show significant differences between the two cases, alpha-catenin was more expressed in sporadic colon adenomas with severe dysplasia and carcinomas than in their UC-associated counterparts. Membranous beta-catenin staining was stronger in UC-associated neoplasms, whereas sporadic lesions had greater cytoplasmic and nuclear expression.
CONCLUSIONS: The differences in cell adhesion molecule expression suggests that UC-associated and sporadic colon neoplasms arise from different pathways of tumorigenesis. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951334     DOI: 10.1002/1097-0142(20000815)89:4<733::aid-cncr3>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

Review 1.  Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.

Authors:  Helmut Neumann; Michael Vieth; Cord Langner; Markus F Neurath; Jonas Mudter
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 2.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

3.  Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.

Authors:  Nermeen S Youssef; Wesam M Osman
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Colon Macrophages Polarized by Commensal Bacteria Cause Colitis and Cancer through the Bystander Effect.

Authors:  Yonghong Yang; Xingmin Wang; Thomas Huycke; Danny R Moore; Stanley A Lightfoot; Mark M Huycke
Journal:  Transl Oncol       Date:  2013-10-01       Impact factor: 4.243

5.  A novel mouse model for colitis-associated colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sulfate sodium.

Authors:  Jian-Guo Wang; Dong-Fei Wang; Bing-Jian Lv; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

Review 6.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

7.  Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma.

Authors:  Adam Elzagheid; Abdelbaset Buhmeida; Eija Korkeila; Yrjo Collan; Kari Syrjanen; Seppo Pyrhonen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

8.  Colocalization of β-catenin with Notch intracellular domain in colon cancer: a possible role of Notch1 signaling in activation of CyclinD1-mediated cell proliferation.

Authors:  Natarajan Gopalakrishnan; Marimuthu Saravanakumar; Perumal Madankumar; Mani Thiyagu; Halagowder Devaraj
Journal:  Mol Cell Biochem       Date:  2014-07-30       Impact factor: 3.396

9.  Wnt pathway-related gene expression in inflammatory bowel disease.

Authors:  Joann You; Anthony V Nguyen; C Gregory Albers; Fritz Lin; Randall F Holcombe
Journal:  Dig Dis Sci       Date:  2007-10-16       Impact factor: 3.199

10.  Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours.

Authors:  T Yoshida; N Matsumoto; T Mikami; I Okayasu
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.